Terms: = Breast cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
113175 results:
1. Ixabepilone related angiographically silent macular edema.
Köksaldı S; Kayabaşı M; Emre S; Saatci AO
Eur J Ophthalmol; 2024 May; 34(3):NP97-NP100. PubMed ID: 38699790
[TBL] [Abstract] [Full Text] [Related]
2. Patient experiences and needs in cancer care- results from a nationwide cross-sectional study in Germany.
Ziegler E; Klein J; Kofahl C
BMC Health Serv Res; 2024 May; 24(1):572. PubMed ID: 38698426
[TBL] [Abstract] [Full Text] [Related]
3. Effect of postpartum depression and role of infant feeding practices on relative weight of child at 1 and 3 years of age.
Shrestha D; K C Bhandari A; Ogawa K; Tanaka H; Miyayama C; Horikawa R; Urayama KY; Morisaki N
BMC Pregnancy Childbirth; 2024 May; 24(1):336. PubMed ID: 38698333
[TBL] [Abstract] [Full Text] [Related]
4. Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes.
Ping J; Jia G; Cai Q; Guo X; Tao R; Ambrosone C; Huo D; Ambs S; Barnard ME; Chen Y; Garcia-Closas M; Gu J; Hu JJ; John EM; Li CI; Nathanson K; Nemesure B; Olopade OI; Pal T; Press MF; Sanderson M; Sandler DP; Yoshimatsu T; Adejumo PO; Ahearn T; Brewster AM; Hennis AJM; Makumbi T; Ndom P; O'Brien KM; Olshan AF; Oluwasanu MM; Reid S; Yao S; Butler EN; Huang M; Ntekim A; Li B; Troester MA; Palmer JR; Haiman CA; Long J; Zheng W
Nat Commun; 2024 May; 15(1):3718. PubMed ID: 38697998
[TBL] [Abstract] [Full Text] [Related]
5. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract] [Full Text] [Related]
6. The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
van Maaren MC; van Hoeve JC; Korevaar JC; van Hezewijk M; Siemerink EJM; Zeillemaker AM; Klaassen-Dekker A; van Uden DJP; Volders JH; Drossaert CHC; Siesling S;
Support Care Cancer; 2024 May; 32(5):323. PubMed ID: 38695938
[TBL] [Abstract] [Full Text] [Related]
7. Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study.
van Veghel W; van Dijk SC; Klem TM; Weel AE; Bügel JB; Birnie E
BMJ Open; 2024 May; 14(5):e080257. PubMed ID: 38692726
[TBL] [Abstract] [Full Text] [Related]
8. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With breast cancer.
Shaw JA; Page K; Wren E; de Bruin EC; Kalashnikova E; Hastings R; McEwen R; Zhang E; Wadsley M; Acheampong E; Renner D; Gleason KLT; Ambasager B; Stetson D; Fernandez-Garcia D; Guttery D; Allsopp RC; Rodriguez A; Zimmermann B; Sethi H; Aleshin A; Liu MC; Richards C; Stebbing J; Ali S; Rehman F; Cleator S; Kenny L; Ahmed S; Armstrong AC; Coombes RC
JCO Precis Oncol; 2024 Apr; 8():e2300456. PubMed ID: 38691816
[TBL] [Abstract] [Full Text] [Related]
9. pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells.
Mahmoudi-Filabadi F; Doosti A
Amino Acids; 2024 May; 56(1):34. PubMed ID: 38691208
[TBL] [Abstract] [Full Text] [Related]
10. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
11. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
[No Abstract] [Full Text] [Related]
12. Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
Inakami K; Fujita N; Iguchi C; Enomoto Y; Minohata J; Sata A; Miyagawa Y; Yanagisawa T; Saitoh T; Nomura T; Sawai Y; Takahara K; Kasugai T; Shiba E
J Med Case Rep; 2024 May; 18(1):214. PubMed ID: 38689362
[TBL] [Abstract] [Full Text] [Related]
13. Diffusion probabilistic versus generative adversarial models to reduce contrast agent dose in breast MRI.
Müller-Franzes G; Huck L; Bode M; Nebelung S; Kuhl C; Truhn D; Lemainque T
Eur Radiol Exp; 2024 May; 8(1):53. PubMed ID: 38689178
[TBL] [Abstract] [Full Text] [Related]
14. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
15. Evolution of neoadjuvant therapy for breast cancer regimens over 12 years and pathologic response rates according to tumor subtypes and clinical stage: A single-center retrospective study.
Li Z; Wang Y
J Cancer Res Ther; 2024 Apr; 20(2):608-614. PubMed ID: 38687931
[TBL] [Abstract] [Full Text] [Related]
16. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
[TBL] [Abstract] [Full Text] [Related]
17. BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage Study.
Cozzi A; Pinker K; Hidber A; Zhang T; Bonomo L; Lo Gullo R; Christianson B; Curti M; Rizzo S; Del Grande F; Mann RM; Schiaffino S
Radiology; 2024 Apr; 311(1):e232133. PubMed ID: 38687216
[TBL] [Abstract] [Full Text] [Related]
18. Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS.
Chairunnisa DF; Harahap Y; Juanita M; Syafhan NF; Purwanto DJ
Pak J Biol Sci; 2024 Mar; 27(3):125-131. PubMed ID: 38686734
[TBL] [Abstract] [Full Text] [Related]
19. Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study.
Mikesell L; O'Malley DM; Kurtzman RT; Howard J; Bates B; Hemler JR; Fadem SJ; Ferrante JM; Bator A; Hudson SV; Crabtree BF
Cancer Med; 2024 May; 13(9):e7219. PubMed ID: 38686635
[TBL] [Abstract] [Full Text] [Related]
20. A Scoping Review of Innervated breast Reconstruction.
Raman S; Daniele E; Daniele KA; Choudhary A; Purnell CA; Ranzer M
Ann Plast Surg; 2024 May; 92(5):591-596. PubMed ID: 38685499
[TBL] [Abstract] [Full Text] [Related]
[Next]
